Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components.
Adequan® i.m.
(polysulfated glycosaminoglycan) is the only FDA-approved treatment proven to
relieve symptoms of non-infectious degenerative osteoarthritis, to stimulate
cartilage repair and reverse the joint disease process. There is no generic
version of Adequan® i.m. Studies have not been conducted to establish safety in
breeding horses. WARNING: Do not use in horses intended for human consumption.
Not for use in humans. Keep this and all medications out of the reach of
children. Caution: Federal law restricts this drug to use by or on the order
of a licensed veterinarian. See product package insert for full prescribing
information.
Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components.
Adequan® i.m.
(polysulfated glycosaminoglycan).